Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Hospitals, clinics and drugmakers clash over 340B contract‑pharmacy rules; committee defers decision
Summary
Senators heard testimony for and against a bill aimed at regulating 340B contract‑pharmacy access, with clinics and hospitals warning of local access problems and manufacturers raising legal concerns; the committee deferred action.
Senators heard extended testimony and sharply differing views on a bill aimed at regulating access to medicines purchased under the federal 340B discount program and distributed through contract pharmacies.
Community health centers, hospital systems and patient advocates said the measure would help ensure patients served by safety‑net providers can obtain discounted drugs locally. "They are 3 patients who live with type 1 diabetes who cannot access insulin at contract pharmacies because there are no manufacturers who are willing to ship it to our contract pharmacies," testified Melissa Boomgaarden, director of pharmacy services for a…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
